Real-Time Oncology Review Speeds Supplements At US FDA, But Gives Modest Benefit For Novel Agents

 
• By Bridget Silverman
  
Fast Stream
RTOR has produced a steady stream of fast approvals. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers